{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Diogo\\AppData\\Local\\Temp\\ipykernel_38124\\3420071597.py:72: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
      "  df = df.append(dict, ignore_index=True)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>RNEC Number</th>\n",
       "      <th>EudraCT Number</th>\n",
       "      <th>Protocol Number</th>\n",
       "      <th>Type of Study</th>\n",
       "      <th>Sponsor's Name</th>\n",
       "      <th>Title of the trial</th>\n",
       "      <th>Recruitment Status</th>\n",
       "      <th>Date of Global End</th>\n",
       "      <th>Infarmed Authorization Date</th>\n",
       "      <th>CEC Opinion Date</th>\n",
       "      <th>Non-technical title</th>\n",
       "      <th>Paediatric Investigation Plan</th>\n",
       "      <th>Medical condition(s)</th>\n",
       "      <th>Therapeutic Confirmatory (Phase II)</th>\n",
       "      <th>Therapeutic Confirmatory (Phase III)</th>\n",
       "      <th>Therapeutic Confirmatory (Phase IV)</th>\n",
       "      <th>Age_Range</th>\n",
       "      <th>Gender</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>181</td>\n",
       "      <td>2016-004740-11</td>\n",
       "      <td>MK-3475-522</td>\n",
       "      <td>Interventional studies with investigational me...</td>\n",
       "      <td>Merck Sharp &amp; Dohme Corp., a subsidiary of Mer...</td>\n",
       "      <td>A Phase III, Randomized, Double-blind Study to...</td>\n",
       "      <td>Active</td>\n",
       "      <td>None</td>\n",
       "      <td>20/03/2017</td>\n",
       "      <td>21/03/2017</td>\n",
       "      <td>A Phase III, Randomized, Double-blind Study to...</td>\n",
       "      <td>No</td>\n",
       "      <td>Neoadjuvant and adjuvant treatment for locally...</td>\n",
       "      <td>None</td>\n",
       "      <td>Yes</td>\n",
       "      <td>None</td>\n",
       "      <td>Adult , Elderly</td>\n",
       "      <td>Female , Male</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>221</td>\n",
       "      <td>2016-002744-17</td>\n",
       "      <td>MA39189</td>\n",
       "      <td>Interventional studies with investigational me...</td>\n",
       "      <td>F. Hoffmann-La Roche Ltd</td>\n",
       "      <td>MULTICENTER, INTERNATIONAL, DOUBLEBLIND, TWO-A...</td>\n",
       "      <td>Active</td>\n",
       "      <td>None</td>\n",
       "      <td>07/04/2017</td>\n",
       "      <td>28/07/2017</td>\n",
       "      <td>A Study of Pirfenidone in Patients with Unclas...</td>\n",
       "      <td>No</td>\n",
       "      <td>Fibrosing interstitial lung disease (ILD) of u...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Adult , Elderly</td>\n",
       "      <td>Female , Male</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>241</td>\n",
       "      <td>2011-005249-12</td>\n",
       "      <td>EFC11759</td>\n",
       "      <td>Interventional studies with investigational me...</td>\n",
       "      <td>Genzyme Corporation</td>\n",
       "      <td>A Two Year, Multicenter, Randomized, Double-Bl...</td>\n",
       "      <td>Not Commenced</td>\n",
       "      <td>None</td>\n",
       "      <td>08/03/2017</td>\n",
       "      <td>28/04/2017</td>\n",
       "      <td>Efficacy, Safety and Pharmacokinetics of Terif...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Multiple Sclerosis</td>\n",
       "      <td>None</td>\n",
       "      <td>Yes</td>\n",
       "      <td>None</td>\n",
       "      <td>Under 18</td>\n",
       "      <td>Female , Male</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>302</td>\n",
       "      <td>2015-004477-32</td>\n",
       "      <td>CAIN457F2366</td>\n",
       "      <td>Interventional studies with investigational me...</td>\n",
       "      <td>Novartis Pharma AG</td>\n",
       "      <td>A randomized, double-blind, active control, mu...</td>\n",
       "      <td>Ended</td>\n",
       "      <td>None</td>\n",
       "      <td>19/04/2017</td>\n",
       "      <td>26/04/2017</td>\n",
       "      <td>Efficacy of secukinumab compared to adalimumab...</td>\n",
       "      <td>No</td>\n",
       "      <td>Psoriatic Arthritis</td>\n",
       "      <td>None</td>\n",
       "      <td>Yes</td>\n",
       "      <td>None</td>\n",
       "      <td>Adult , Elderly</td>\n",
       "      <td>Female , Male</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>721</td>\n",
       "      <td>2016-004015-13</td>\n",
       "      <td>FMD-TRI-2016-01</td>\n",
       "      <td>Interventional studies with investigational me...</td>\n",
       "      <td>Ferrer Internacional S.A</td>\n",
       "      <td>A phase III, international, multicenter, rando...</td>\n",
       "      <td>Active</td>\n",
       "      <td>None</td>\n",
       "      <td>28/04/2017</td>\n",
       "      <td>05/06/2017</td>\n",
       "      <td>Clinical study to evaluate the efficacy on cho...</td>\n",
       "      <td>No</td>\n",
       "      <td>Very high cardiovascular risk without previous...</td>\n",
       "      <td>None</td>\n",
       "      <td>Yes</td>\n",
       "      <td>None</td>\n",
       "      <td>Adult , Elderly</td>\n",
       "      <td>Female , Male</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>589</th>\n",
       "      <td>18882</td>\n",
       "      <td>2021-005528-39</td>\n",
       "      <td>78934804UCO2001</td>\n",
       "      <td>Interventional studies with investigational me...</td>\n",
       "      <td>Janssen-Cilag International N.V.</td>\n",
       "      <td>A Phase 2b Randomized, Double-blind, Active-an...</td>\n",
       "      <td>Not Commenced</td>\n",
       "      <td>None</td>\n",
       "      <td>28/03/2023</td>\n",
       "      <td>13/02/2023</td>\n",
       "      <td>Efficacy and Safety of Combination Therapy wit...</td>\n",
       "      <td>No</td>\n",
       "      <td>Moderately to Severely Active Ulcerative Colit...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Adult</td>\n",
       "      <td>Female , Male</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>590</th>\n",
       "      <td>18902</td>\n",
       "      <td>2022-002222-27</td>\n",
       "      <td>STAR-221</td>\n",
       "      <td>Interventional studies with investigational me...</td>\n",
       "      <td>Arcus Biosciences, Inc.</td>\n",
       "      <td>A Randomized, Open-Label, Multicenter Phase 3 ...</td>\n",
       "      <td>Not Commenced</td>\n",
       "      <td>None</td>\n",
       "      <td>19/04/2023</td>\n",
       "      <td>03/03/2023</td>\n",
       "      <td>A phase 3 clinical trial of a new combination ...</td>\n",
       "      <td>No</td>\n",
       "      <td>Metastatic Esophageal or Gastric Cancer</td>\n",
       "      <td>None</td>\n",
       "      <td>Yes</td>\n",
       "      <td>None</td>\n",
       "      <td>Adult , Elderly</td>\n",
       "      <td>Female , Male</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>591</th>\n",
       "      <td>18942</td>\n",
       "      <td>2020-003571-17</td>\n",
       "      <td>CY6022</td>\n",
       "      <td>Interventional studies with investigational me...</td>\n",
       "      <td>Cytokinetics, Inc.</td>\n",
       "      <td>An Open-Label Study of CK-3773274 for Patients...</td>\n",
       "      <td>Not Commenced</td>\n",
       "      <td>None</td>\n",
       "      <td>31/03/2023</td>\n",
       "      <td>14/04/2023</td>\n",
       "      <td>This study is performed to collect long term s...</td>\n",
       "      <td>No</td>\n",
       "      <td>symptomatic hypertrophic cardiomyopathy (HCM)</td>\n",
       "      <td>Yes</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Adult , Elderly</td>\n",
       "      <td>Female , Male</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>592</th>\n",
       "      <td>18982</td>\n",
       "      <td>2022-002489-34</td>\n",
       "      <td>AV-APL-B-002-22</td>\n",
       "      <td>Interventional studies with investigational me...</td>\n",
       "      <td>PharmaMar, S.A.</td>\n",
       "      <td>A Multicentre, Open label, Randomised, Control...</td>\n",
       "      <td>Not Commenced</td>\n",
       "      <td>None</td>\n",
       "      <td>03/01/2023</td>\n",
       "      <td>16/12/2022</td>\n",
       "      <td>A Multicentre, Open label, Randomised, Control...</td>\n",
       "      <td>No</td>\n",
       "      <td>Immunocompromised Adult Patients with Symptoma...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Adult , Elderly</td>\n",
       "      <td>Female , Male</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>593</th>\n",
       "      <td>19022</td>\n",
       "      <td>2022-002691-36</td>\n",
       "      <td>CVAY736F12301</td>\n",
       "      <td>Interventional studies with investigational me...</td>\n",
       "      <td>Novartis Pharma AG</td>\n",
       "      <td>A randomized, double-blind, parallel group, pl...</td>\n",
       "      <td>Not Commenced</td>\n",
       "      <td>None</td>\n",
       "      <td>17/04/2023</td>\n",
       "      <td>05/05/2023</td>\n",
       "      <td>Phase 3 study to evaluate two regimens of iana...</td>\n",
       "      <td>No</td>\n",
       "      <td>Systemic Lupus Erythematosus</td>\n",
       "      <td>None</td>\n",
       "      <td>Yes</td>\n",
       "      <td>None</td>\n",
       "      <td>Under 18 , Adult , Elderly</td>\n",
       "      <td>Female , Male</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>594 rows × 18 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    RNEC Number  EudraCT Number  Protocol Number  \\\n",
       "0           181  2016-004740-11      MK-3475-522   \n",
       "1           221  2016-002744-17          MA39189   \n",
       "2           241  2011-005249-12         EFC11759   \n",
       "3           302  2015-004477-32     CAIN457F2366   \n",
       "4           721  2016-004015-13  FMD-TRI-2016-01   \n",
       "..          ...             ...              ...   \n",
       "589       18882  2021-005528-39  78934804UCO2001   \n",
       "590       18902  2022-002222-27         STAR-221   \n",
       "591       18942  2020-003571-17           CY6022   \n",
       "592       18982  2022-002489-34  AV-APL-B-002-22   \n",
       "593       19022  2022-002691-36    CVAY736F12301   \n",
       "\n",
       "                                         Type of Study  \\\n",
       "0    Interventional studies with investigational me...   \n",
       "1    Interventional studies with investigational me...   \n",
       "2    Interventional studies with investigational me...   \n",
       "3    Interventional studies with investigational me...   \n",
       "4    Interventional studies with investigational me...   \n",
       "..                                                 ...   \n",
       "589  Interventional studies with investigational me...   \n",
       "590  Interventional studies with investigational me...   \n",
       "591  Interventional studies with investigational me...   \n",
       "592  Interventional studies with investigational me...   \n",
       "593  Interventional studies with investigational me...   \n",
       "\n",
       "                                        Sponsor's Name  \\\n",
       "0    Merck Sharp & Dohme Corp., a subsidiary of Mer...   \n",
       "1                             F. Hoffmann-La Roche Ltd   \n",
       "2                                  Genzyme Corporation   \n",
       "3                                   Novartis Pharma AG   \n",
       "4                             Ferrer Internacional S.A   \n",
       "..                                                 ...   \n",
       "589                   Janssen-Cilag International N.V.   \n",
       "590                            Arcus Biosciences, Inc.   \n",
       "591                                 Cytokinetics, Inc.   \n",
       "592                                    PharmaMar, S.A.   \n",
       "593                                 Novartis Pharma AG   \n",
       "\n",
       "                                    Title of the trial Recruitment Status  \\\n",
       "0    A Phase III, Randomized, Double-blind Study to...             Active   \n",
       "1    MULTICENTER, INTERNATIONAL, DOUBLEBLIND, TWO-A...             Active   \n",
       "2    A Two Year, Multicenter, Randomized, Double-Bl...      Not Commenced   \n",
       "3    A randomized, double-blind, active control, mu...              Ended   \n",
       "4    A phase III, international, multicenter, rando...             Active   \n",
       "..                                                 ...                ...   \n",
       "589  A Phase 2b Randomized, Double-blind, Active-an...      Not Commenced   \n",
       "590  A Randomized, Open-Label, Multicenter Phase 3 ...      Not Commenced   \n",
       "591  An Open-Label Study of CK-3773274 for Patients...      Not Commenced   \n",
       "592  A Multicentre, Open label, Randomised, Control...      Not Commenced   \n",
       "593  A randomized, double-blind, parallel group, pl...      Not Commenced   \n",
       "\n",
       "    Date of Global End Infarmed Authorization Date CEC Opinion Date  \\\n",
       "0                 None                  20/03/2017       21/03/2017   \n",
       "1                 None                  07/04/2017       28/07/2017   \n",
       "2                 None                  08/03/2017       28/04/2017   \n",
       "3                 None                  19/04/2017       26/04/2017   \n",
       "4                 None                  28/04/2017       05/06/2017   \n",
       "..                 ...                         ...              ...   \n",
       "589               None                  28/03/2023       13/02/2023   \n",
       "590               None                  19/04/2023       03/03/2023   \n",
       "591               None                  31/03/2023       14/04/2023   \n",
       "592               None                  03/01/2023       16/12/2022   \n",
       "593               None                  17/04/2023       05/05/2023   \n",
       "\n",
       "                                   Non-technical title  \\\n",
       "0    A Phase III, Randomized, Double-blind Study to...   \n",
       "1    A Study of Pirfenidone in Patients with Unclas...   \n",
       "2    Efficacy, Safety and Pharmacokinetics of Terif...   \n",
       "3    Efficacy of secukinumab compared to adalimumab...   \n",
       "4    Clinical study to evaluate the efficacy on cho...   \n",
       "..                                                 ...   \n",
       "589  Efficacy and Safety of Combination Therapy wit...   \n",
       "590  A phase 3 clinical trial of a new combination ...   \n",
       "591  This study is performed to collect long term s...   \n",
       "592  A Multicentre, Open label, Randomised, Control...   \n",
       "593  Phase 3 study to evaluate two regimens of iana...   \n",
       "\n",
       "    Paediatric Investigation Plan  \\\n",
       "0                              No   \n",
       "1                              No   \n",
       "2                             Yes   \n",
       "3                              No   \n",
       "4                              No   \n",
       "..                            ...   \n",
       "589                            No   \n",
       "590                            No   \n",
       "591                            No   \n",
       "592                            No   \n",
       "593                            No   \n",
       "\n",
       "                                  Medical condition(s)  \\\n",
       "0    Neoadjuvant and adjuvant treatment for locally...   \n",
       "1    Fibrosing interstitial lung disease (ILD) of u...   \n",
       "2                                   Multiple Sclerosis   \n",
       "3                                  Psoriatic Arthritis   \n",
       "4    Very high cardiovascular risk without previous...   \n",
       "..                                                 ...   \n",
       "589  Moderately to Severely Active Ulcerative Colit...   \n",
       "590            Metastatic Esophageal or Gastric Cancer   \n",
       "591     symptomatic hypertrophic cardiomyopathy (HCM)    \n",
       "592  Immunocompromised Adult Patients with Symptoma...   \n",
       "593                       Systemic Lupus Erythematosus   \n",
       "\n",
       "    Therapeutic Confirmatory (Phase II) Therapeutic Confirmatory (Phase III)  \\\n",
       "0                                  None                                  Yes   \n",
       "1                                   Yes                                 None   \n",
       "2                                  None                                  Yes   \n",
       "3                                  None                                  Yes   \n",
       "4                                  None                                  Yes   \n",
       "..                                  ...                                  ...   \n",
       "589                                 Yes                                 None   \n",
       "590                                None                                  Yes   \n",
       "591                                 Yes                                 None   \n",
       "592                                 Yes                                 None   \n",
       "593                                None                                  Yes   \n",
       "\n",
       "    Therapeutic Confirmatory (Phase IV)                   Age_Range  \\\n",
       "0                                  None             Adult , Elderly   \n",
       "1                                  None             Adult , Elderly   \n",
       "2                                  None                    Under 18   \n",
       "3                                  None             Adult , Elderly   \n",
       "4                                  None             Adult , Elderly   \n",
       "..                                  ...                         ...   \n",
       "589                                None                       Adult   \n",
       "590                                None             Adult , Elderly   \n",
       "591                                None             Adult , Elderly   \n",
       "592                                None             Adult , Elderly   \n",
       "593                                None  Under 18 , Adult , Elderly   \n",
       "\n",
       "            Gender  \n",
       "0    Female , Male  \n",
       "1    Female , Male  \n",
       "2    Female , Male  \n",
       "3    Female , Male  \n",
       "4    Female , Male  \n",
       "..             ...  \n",
       "589  Female , Male  \n",
       "590  Female , Male  \n",
       "591  Female , Male  \n",
       "592  Female , Male  \n",
       "593  Female , Male  \n",
       "\n",
       "[594 rows x 18 columns]"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from selenium import webdriver\n",
    "from selenium.webdriver.common.by import By\n",
    "import time\n",
    "import pandas as pd\n",
    "from bs4 import BeautifulSoup\n",
    "\n",
    "fields = ['t83','t87','t91','t95','t99','t103','t107','t109','t115','t119','t123','t129','t134','t158','t164','t170']\n",
    "keys = ['RNEC Number',\n",
    "        'EudraCT Number',\n",
    "        'Protocol Number',\n",
    "        'Type of Study',\n",
    "        \"Sponsor's Name\",\n",
    "        'Title of the trial',\n",
    "        'Recruitment Status',\n",
    "        'Date of Global End',\n",
    "        'Infarmed Authorization Date',\n",
    "        'CEC Opinion Date',\n",
    "        'Non-technical title',\n",
    "        'Paediatric Investigation Plan',\n",
    "        'Medical condition(s)',\n",
    "        'Therapeutic Confirmatory (Phase II)',\n",
    "        'Therapeutic Confirmatory (Phase III)',\n",
    "        'Therapeutic Confirmatory (Phase IV)',\n",
    "        'Age_Range',\n",
    "        'Gender'\n",
    "        ]\n",
    "\n",
    "\n",
    "data = []\n",
    "df = pd.DataFrame(columns=keys)\n",
    "\n",
    "\n",
    "driver = webdriver.Chrome()\n",
    "driver.get(\"https://www.rnec.pt/pesquisa-de-estudos-clinicos\")\n",
    "study_num = (0, 1)\n",
    "\n",
    "\n",
    "\n",
    "# Initialization -  search button click and Html Refresh (clicks page1)\n",
    "search_button = driver.find_element(By.ID, '_RNECPesquisaEstudosClinicos_WAR_RNECPesquisaEstudosClinicosportlet_:mainForm:j_idt73').click()\n",
    "driver.implicitly_wait(15)\n",
    "page_1_update = driver.find_element(By.XPATH, '//*[@id=\"_RNECPesquisaEstudosClinicos_WAR_RNECPesquisaEstudosClinicosportlet_:mainForm:j_idt79_paginator_bottom\"]/span[3]/span[1]').click()\n",
    "\n",
    "for page in range (1,298):\n",
    "    page_html = driver.page_source\n",
    "    soup = BeautifulSoup(page_html, 'html.parser')\n",
    "    for study in study_num:\n",
    "        study_data = []\n",
    "        for field in fields:\n",
    "            try:\n",
    "                element = soup.find(id=f'_RNECPesquisaEstudosClinicos_WAR_RNECPesquisaEstudosClinicosportlet_:mainForm:j_idt79:{study}:j_id{field}')['value']\n",
    "                         \n",
    "            except:\n",
    "                element = None\n",
    "            study_data.append(element)\n",
    "        try:\n",
    "            age_range= soup.find('label', {'id': f'_RNECPesquisaEstudosClinicos_WAR_RNECPesquisaEstudosClinicosportlet_:mainForm:j_idt79:{study}:j_idt173'}).parent.find_next_sibling().text.strip()\n",
    "            gender = soup.find('label', {'id': f'_RNECPesquisaEstudosClinicos_WAR_RNECPesquisaEstudosClinicosportlet_:mainForm:j_idt79:{study}:j_idt181'}).parent.find_next_sibling().text.strip()\n",
    "        except:\n",
    "            age_range = None\n",
    "            gender = None\n",
    "        study_data.append(age_range)\n",
    "        study_data.append(gender)\n",
    "        data.append(study_data)\n",
    "    \n",
    "    study_num = tuple([x + 2 for x in study_num])\n",
    "    next_page = driver.find_element(By.XPATH, '//*[@id=\"_RNECPesquisaEstudosClinicos_WAR_RNECPesquisaEstudosClinicosportlet_:mainForm:j_idt79_paginator_bottom\"]/span[4]/span').click()\n",
    "    time.sleep(2)\n",
    "    \n",
    "    \n",
    "dict = [{k:v for k,v in zip(keys, d)} for d in data]\n",
    "df = df.append(dict, ignore_index=True)\n",
    "df.to_csv('RNEC.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "RNEC Number                               2\n",
       "EudraCT Number                            2\n",
       "Protocol Number                           2\n",
       "Type of Study                             2\n",
       "Sponsor's Name                            2\n",
       "Title of the trial                        2\n",
       "Recruitment Status                       34\n",
       "Date of Global End                      594\n",
       "Infarmed Authorization Date               2\n",
       "CEC Opinion Date                          4\n",
       "Non-technical title                       4\n",
       "Paediatric Investigation Plan             2\n",
       "Medical condition(s)                      2\n",
       "Therapeutic Confirmatory (Phase II)     432\n",
       "Therapeutic Confirmatory (Phase III)    166\n",
       "Therapeutic Confirmatory (Phase IV)     562\n",
       "Age_Range                                 2\n",
       "Gender                                    2\n",
       "dtype: int64"
      ]
     },
     "execution_count": 80,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.isna().sum()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Study",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.16"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
